Neil Minkoff, MD: One of the things we had already touched on was patients ending up in the hospital in the emergency department [ED], and the overall clinical and economic ramifications of the ...

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) is a prescription drug used to treat COPD. With COPD, you have lung damage that worsens over time ...

Neil Minkoff, MD: That’s such an important aspect in terms of balancing what’s right for each patient. I’m going to pull Dr Drummond in here to comment on that further. We started touching on the idea ...

Please provide your email address to receive an email when new articles are posted on . A Montreal Cognitive Assessment score of 16 or less, which implies dementia, predicted errors in using inhalers.

Inhalers are the frontline treatment for asthma and COPD, but they come with a steep environmental cost, according to a new UCLA Health study - the largest to date quantifying inhaler-related ...

Various types of inhalers, including short- and long-lasting options, are available for managing chronic obstructive pulmonary disease (COPD). A person can get a COPD inhaler through Medicare Part D ...

person holding blue asthma inhaler Researchers examined real-world characteristics of patients receiving albuterol multidose dry powder inhaler or short-acting β2 agonists with short-acting β2 ...

Miami (June 17, 2025) – Digital inhalers may help predict impending acute exacerbations of chronic obstructive pulmonary disease (COPD), according to a new study. The study is published in the May ...

The study, published in the Journal of the American Medical Association (JAMA) on Monday, found that inhalers used by US ...

Every time Ashley publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

Inhalers are the frontline treatment for asthma and COPD, but they come with a steep environmental cost, according to a new UCLA Health study—the largest to date quantifying inhaler-related emissions ...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the launch of Inhaler Tales – a national ...